Centre for Drug Delivery Research, The School of Pharmacy, University of London, 29/39 Brunswick Square, London WC1N 1AX, United Kingdom.
J Control Release. 2012 Jul 20;161(2):399-402. doi: 10.1016/j.jconrel.2011.11.005. Epub 2011 Nov 12.
This paper briefly discusses reductionism as a process for dissecting the complexities of drug targeting mediated by nanoparticulate carriers. While reductionism has been said to have been a drawback to enhanced appreciation and understanding of complex biological systems, it is concluded here that the dissection of the individual stages of the procession from injection to final destination in specific targets in a living complex organism is essential. It should allow a decrease in the empiricism from laudable and inventive efforts to achieve high levels of drug delivery to specific diseased targets such as tumours. At the stage of development of the field there have perhaps been fewer than desirable detailed experimental or theoretical investigations of these individual stages. However, there are frequently analogies in the literature from which to draw at least tentative conclusions about the physics, physical chemistry and biology which underpin the processes involved.
本文简要讨论了还原论作为一种方法,用于剖析纳米载体介导的药物靶向的复杂性。虽然有人说还原论是增强对复杂生物系统的理解和认识的一个障碍,但本文得出的结论是,对从注射到特定活复杂生物体中的最终目标的整个过程的各个阶段进行剖析是必不可少的。这应该可以减少从值得称赞和富有创意的努力中获得的经验主义,以实现将药物递送到特定疾病靶点(如肿瘤)的高水准。在该领域的发展阶段,对这些单个阶段的详细实验或理论研究可能并不理想。然而,文献中经常有类似的情况,可以从中得出关于支撑所涉及过程的物理、物理化学和生物学的至少初步结论。